Compare NATR & ARDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NATR | ARDC |
|---|---|---|
| Founded | 1972 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 389.1M | 317.5M |
| IPO Year | N/A | N/A |
| Metric | NATR | ARDC |
|---|---|---|
| Price | $22.59 | $13.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.33 | N/A |
| AVG Volume (30 Days) | 86.0K | ★ 115.8K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.84% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $474,542,000.00 | N/A |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $27.67 | ★ N/A |
| Revenue Growth | ★ 6.62 | N/A |
| 52 Week Low | $11.01 | $11.56 |
| 52 Week High | $24.12 | $14.30 |
| Indicator | NATR | ARDC |
|---|---|---|
| Relative Strength Index (RSI) | 60.81 | 62.03 |
| Support Level | $21.88 | $13.24 |
| Resistance Level | $23.05 | $13.74 |
| Average True Range (ATR) | 0.77 | 0.11 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 80.28 | 77.91 |
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
Ares Dynamic Credit Allocation Fund Inc is a closed-ended, diversified management investment company. The fund's investment objective is to provide an attractive level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of senior secured loans (Senior Loans) made to companies whose debt is rated below investment grade; corporate bonds (Corporate Bonds) that are high yield issues rated below investment grade; other fixed-income instruments of a similar nature that may be represented by derivatives; and securities of collateralized loan obligations (CLOs).